Phase II Study on Voriconazole for Treatment of Chinese Patients with Malignant Hematological Disorders and Invasive Aspergillosis |
Zhang, Xue-Zhong
(Hematology Department of Nanjing First Hospital, Nanjing Medical University)
Huang, Xin-En (Department of Chemotherapy, JiangSu Cancer Hospital and Research Institute) Xu, Yan-Li (Hematology Department of Nanjing First Hospital, Nanjing Medical University) Zhang, Xiu-Qun (Hematology Department of Nanjing First Hospital, Nanjing Medical University) Su, Ai-ling (Hematology Department of Nanjing First Hospital, Nanjing Medical University) Shen, Zheng-Shan (Hematology Department of Nanjing First Hospital, Nanjing Medical University) |
1 | Baddley JW, Andes DR, Marr KA, et al (2012). Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol. 2012 Jun 11. |
2 | Egerer G, Reichert D, Pletz MW, et al (2012). Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry. Eur J Med Res, 17, 7. DOI |
3 | Herbrecht R, Denning DW, Patterson TF, et al (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med, 347, 408-15. DOI ScienceOn |
4 | Hilde VC, Sophie M, Marie-Paule D, et al (2008). Voriconazole treatment of invasive aspergillosis. Clin Drug Invest, 28, 509-21. DOI |
5 | Hoenigl M, Strenger V, Buzina W, et al (2012). European Organization for the Research and Treatment of Cancer/ Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother. published online on May 7, 2012 and accessed on Jun 2nd, 2012. |
6 | Horbrecht R, Letscher-Bru V, Oprea C, et al (2002). Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol, 20, 1898-906. DOI |
7 | Huang XE, Hirose K, Wakai K, et al (2004). Comparison of lifestyle risk factors by family history for gastric, breast, lung and colorectal cancer. Asian Pac J Cancer Prev, 5, 419-27. |
8 | Huang XE, Li CG, Li Y, et al (2011). European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. Asian Pac J Cancer Prev, 12, 2797-800. |
9 | Georgiadou SP, Kontoyiannis DP, et al (2012). Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: How firm is the Aspergillus diagnosis? J Infect. 2012 May 9. |
10 | Godet C, Elsendoorn A, Roblot F, et al (2012). Benefit of CT scanning for assessing pulmonary disease in the immunodepressed patient. Diagn Interv Imaging, 93, 425-30. DOI |
11 | Gong P, Huang XE, Chen CY, et al (2012). Comparison on complications of peripherally inserted central catheters by ultrasound guide or conventional method in cancer patients. Asian Pac J Cancer Prev, in press. |
12 | Hadrich I, Makni F, Neji S, et al (2012). Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012 May 15. |
13 | Jiang Y, Huang XE, Yan PW, et al (2010). Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy. Asian Pacific J Cancer Prev, 11, 1059-62. |
14 | Kriengkauykiat J, Ito JI, Dadwal SS (2011). Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol, 3, 175-91. |
15 | Li CG, Huang XE, Li Y, et al (2011). Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer. Asian Pac J Cancer Prev, 12, 487-90. |
16 | Li Y, Yan PW, Huang XE, et al (2011). MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev, 12, 2405-9. |
17 | Mengoli C, Cruciani M, Barnes RA, et al (2009). Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis, 9, 89-96. DOI |
18 | Metzke B, Neubauer WC, Hieke S, et al (2012). Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysis. Pharmacoepidemiol Drug Saf. published online on 2012 May 28. doi: 10.1002/pds.3278, and accessed on Jun 2nd, 2012. |
19 | Misra R, Malik A, Singhal S (2011). Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species. Indian J Pathol Microbiol, 54, 112-6. DOI |
20 | Miller MA, DiNunzio J, Matteucci ME, et al (2012). Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Drug Dev Ind Pharm, 38, 557-70. DOI |
21 | Nicolle MC, Bénet T, Thiebaut A, et al (2011). Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica, 96, 1685-91. DOI |
22 | Ohba H, Miwa S, Shirai M, et al (2012). Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med, 106, 724-9. DOI |
23 | Reinwald M, Spiess B, Heinz WJ, et al (2012). Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. Eur J Haematol. 2012 Jun 1. doi: 10.1111/j.1600-0609.2012.01806.x. |
24 | Sambatakou H, Dupont B, Lode H, et al (2006). Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med, 119, 527.e17-24. DOI |
25 | Schwartz S, Reisman A, Troke PF (2011). The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection, 39, 201-10. DOI |
26 | Springer J, Schloßnagel H, Heinz W, et al (2012). A novel extraction method combining plasma with whole blood fraction shows excellent sensitivity and reproducibility in patients at high risk for invasive aspergillosis. J Clin Microbiol. 2012 May 16. |
27 | Wang ZY, Cai JP, Qiu LW, et al (2012). Development of monoclonal antibody-based galactomannoprotein antigencapture ELISAs to detect Aspergillus fumigatus infection in the invasive aspergillosis rabbit models. Eur J Clin Microbiol Infect Dis. 2012 Jun 5. |
28 | Stefan S, Markus R, Patricia R, et al (2005). Improved outcome in central nervous system aspergillosis using voriconazole treatment. Blood, 106, 2641-5. DOI |
29 | Stopiglia CD, Arechavala A, Carissimi M, et al (2012). Standardization and characterization of antigens for the diagnosis of aspergillosis. Can J Microbiol, 58, 455-62. DOI |
30 | Tabarsi P, Soraghi A, Marjani M, et al (2012). Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients. Exp Clin Transplant, 10, 278-81. DOI |
31 | White PL, Bretagne S, Klingspor L, et al (2010). Aspergillus PCR: one step closer to standardization. J Clin Microbiol, 48, 1231-40. DOI |
32 | Wingard JR, Carter SL, Walsh TJ, et al (2010). Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood, 116, 5111-8. DOI |
33 | Yan PW, Huang XE, Jiang Y, et al (2010). Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC). Asian Pac J Cancer Prev, 11, 1115-8. |
34 | Yuan X, Wang R, Bai CQ, et al(2012). Caspofungin for prophylaxis and treatment of fungal infections in adolescents and adults: a meta-analysis of randomized controlled trials. Pharmazie, 67, 267-73. |
35 | Zhou JN, Huang XE, Ye Z, et al (2009). Weekly paclitaxel/ Docetaxel combined with a paltinum in the treatment of advanced non-samll cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev, 10, 1147-50. |
36 | Yu DS, Huang XE, Zhou JN (2012). A comparative study on the value of anal preserving surgery for aged people with low rectal carcinoma in Jiangsu, China. Asian Pac J Cancer Prev, in press. |